ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD38 Antibody [B-E60] - BSA and Azide free (A342183)

Mouse monoclonal [B-E60] IVD antibody to CD38 for Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD38 Antibody [B-E60] - BSA and Azide free
Description
Mouse monoclonal [B-E60] IVD antibody to CD38.
Specificity
This product recognizes both natural and recombinant human CD38.
Applications
Flow Cytometry
Reactivity
Human
Immunogen
Human thymocytes and Jurkat cell line.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-E60
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG2a Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
2'-phospho-ADP-ribosyl cyclase, 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, ADPRC 1, cADPR hydrolase 1, Cyclic ADP-ribose hydrolase 1, EC:2.4.99.20, T10
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD38 Antibody [B-E60] - BSA and Azide free (A342183)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD38 Antibody [B-E60] - BSA and Azide free (A342183)

Proteins predicted to interact with CD38

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.2% Relevancy Score
96.4% Relevancy Score
95.5% Relevancy Score
95% Relevancy Score
94.6% Relevancy Score
94.3% Relevancy Score
94% Relevancy Score
93.9% Relevancy Score
93.2% Relevancy Score